The protective role of resveratrol in diabetic wound healing
Authors:
- 28 September 2023
- journal article
- review article
- Published by Wiley in Phytotherapy Research
- Vol. 37 (11) , 5193-5204
Abstract
Diabetic wounds are severe complications of diabetes mellitus (DM), which have difficulty in healing. Although diverse treatments have been used, the prognosis of diabetic wounds is not satisfactory; therefore, an effective therapy to accelerate diabetic wound healing is urgently needed. In our review, we summarized that resveratrol can promote diabetic wound healing by protecting against hyperglycemia, inflammation, oxidative stress, vascular pathology, infection, and peripheral neuropathy. To clarify it clearly, we highlighted its underlying mechanisms of protective effects of resveratrol against diabetic wounds, and high‐quality studies are needed to firmly establish its clinical efficacy. Otherwise, with the development of material sciences, resveratrol can exert its therapeutic effectiveness efficiently; however, more high‐quality studies are needed to confirm the clinical efficacy of resveratrol on diabetic wounds.Keywords
Funding Information
- Lanzhou University Second Hospital
This publication has 114 references indexed in Scilit:
- Resveratrol ameliorates high-glucose-induced hyperpermeability mediated by caveolae via VEGF/KDR pathwayGenes & Nutrition, 2012
- The protective role of natural phytoalexin resveratrol on inflammation, fibrosis and regeneration in cholestatic liver injuryMolecular Nutrition & Food Research, 2011
- Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2–Keap1 signalingBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- Resveratrol Acts Not through Anti-Aggregative Pathways but Mainly via Its Scavenging Properties against Aβ and Aβ-Metal Complexes ToxicityPLOS ONE, 2011
- Resveratrol attenuates hyperglycemia-mediated oxidative stress, proinflammatory cytokines and protects hepatocytes ultrastructure in streptozotocin–nicotinamide-induced experimental diabetic ratsChemico-Biological Interactions, 2010
- Matrix Metalloproteinases: Regulators of the Tumor MicroenvironmentCell, 2010
- Anti-inflammatory mechanisms of resveratrol in activated HMC-1 cells: Pivotal roles of NF-κB and MAPKPharmacological Research, 2009
- Resveratrol inhibits expression and binding activity of the monocyte chemotactic protein-1 receptor, CCR2, on THP-1 monocytesAtherosclerosis, 2007
- SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosisThe EMBO Journal, 2007
- Resveratrol Increases Glutamate Uptake, Glutathione Content, and S100B Secretion in Cortical Astrocyte CulturesCellular and Molecular Neurobiology, 2007